Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Jesinghaus

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|April 12, 2023
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancerFabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
Analytical Chemistry|June 11, 2025
Probing Field Cancerization in the Gastrointestinal Tract Using a Hybrid Raman and Partial Wave Spectroscopy MicroscopeElena Kriukova, Mikhail Mazurenka, Sabrina Marcazzan, et al.
Journal of Neuroendocrinology|April 2, 2025
Prognostic value of clinical parameters and exosomal lncRNA NEAT1_1 in MEN1-related non-functioning pancreatic neuroendocrine tumorsJerena Manoharan, Max Albers, Natalia Khizanishvili, et al.
The Journal of Pathology. Clinical Research|September 16, 2022
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen gradingMoritz Jesinghaus, Melanie Boxberg, Maxime Schmitt, et al.
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2020
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterationsBarbara Willvonseder, Fabian Stögbauer, Katja Steiger, et al.
Journal of Neuroendocrinology|January 21, 2024
Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cellsSebastian D Graf, Corinna U Keber, Akira Hattesohl, et al.
British Journal of Cancer|October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classificationBjörn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|April 12, 2023
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancerFabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
Analytical Chemistry|June 11, 2025
Probing Field Cancerization in the Gastrointestinal Tract Using a Hybrid Raman and Partial Wave Spectroscopy MicroscopeElena Kriukova, Mikhail Mazurenka, Sabrina Marcazzan, et al.
Journal of Neuroendocrinology|April 2, 2025
Prognostic value of clinical parameters and exosomal lncRNA NEAT1_1 in MEN1-related non-functioning pancreatic neuroendocrine tumorsJerena Manoharan, Max Albers, Natalia Khizanishvili, et al.
The Journal of Pathology. Clinical Research|September 16, 2022
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen gradingMoritz Jesinghaus, Melanie Boxberg, Maxime Schmitt, et al.
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2020
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterationsBarbara Willvonseder, Fabian Stögbauer, Katja Steiger, et al.
Journal of Neuroendocrinology|January 21, 2024
Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cellsSebastian D Graf, Corinna U Keber, Akira Hattesohl, et al.
British Journal of Cancer|October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classificationBjörn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
Pageof 12